• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Syapse, Pfizer Extends Collaboration to Generate Real-World Evidence in Breast Cancer

by Jasmine Pennic 01/20/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

What You Should Know:

– Syapse, a real-world evidence company that informs cancer care, announced that it will extend its collaboration with Pfizer to generate real-world evidence in breast cancer.

– This is the third phase of the collaboration, which was first announced in 2019 and renewed in 2021.

Generate Real-World Evidence in Breast Cancer

As part of the next phase of the collaboration, Syapse will provide insights and services to Pfizer, using the Syapse Learning Health Network (LHN) to integrate, normalize, de-identify and manage data. The insights gleaned from this collaboration will help grow the breast cancer data cohort and provide Pfizer with in-depth, patient-level insights. Together, the two companies will continue to generate an unparalleled understanding of the oncology patient experience and develop a higher standard of care through real-world evidence. 

– Syapse and Pfizer have co-authored two studies that utilize data from the LHN. The first study, titled “Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the Syapse Learning Health Network,” was presented at the 38th Annual Miami Breast Cancer Conference. The second study, titled “Germline BRCA1/2 Mutation Testing in Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Advanced Breast Cancer (ABC): A Real-World Study in the Syapse Learning Health Network (LHN),” was presented at the 2021 San Antonio Breast Cancer Symposium.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Breast Cancer, cancer, Oncology, Oncology Digital Health Startups, Oncology Platform, Pfizer, Precision Medicine, Precision Medicine Oncology, Precision Oncology, Syapse

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

How AI Helps Health Systems Improve the Quality of Care for Patients with Chronic Conditions

How AI Helps Health Systems Improve the Quality of Care for Patients with Chronic Conditions

10 Critical KPIs Every Successful Healthcare Organization is Implementing10 Critical KPIs Every Successful Healthcare Organization is Implementing

Trending

Why The Evolution of Tech Will be Based on APIs

Why The Evolution of Tech Will be Based on APIs

Podimetrics CMO Talks Supporting Patients Living with SDoH Challenges

Podimetrics Director Talks Supporting Patients Living with SDoH Challenges

: Does Alzheimer’s Cure Matter if We Don't Fix the Economic Infrastructure of the Disease?

Does Alzheimer’s Cure Matter if We Don’t Fix the Economic Infrastructure of the Disease?

Recent Digital Health Partnerships

Roundups: 15 Recent Digital Health Strategic Partnerships

Recent Digital Health Executive Hires & Board Appointments

Digital Health Executive Hires: Practice Better Appoints CEO, HHAeXchange, Intelerad, Tegria, Others

M&A: Florence Acquires Virtual Care Solution Zipnosis

M&A: Florence Acquires Virtual Care Solution Zipnosis

Adopting Value-Based Care Models for Autism Care Is Imperative

Why Adopting Value-Based Care Models for Autism Care Is Imperative

UNC Health to Pilot Epic, Microsoft’s Generative AI Tool

UNC Health to Pilot Epic, Microsoft’s Generative AI Tool

Vanderbilt University Medical Center Taps Philips Reduce Carbon Footprint

Vanderbilt University Medical Center Taps Philips to Reduce Carbon Footprint

Denials Management Named Most Time-Consuming Task in RCM

Denials Management Named Most Time-Consuming Task in RCM

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |